Literature DB >> 12782566

Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.

Michael O Sweeney1, Anne S Hellkamp, Kenneth A Ellenbogen, Arnold J Greenspon, Roger A Freedman, Kerry L Lee, Gervasio A Lamas.   

Abstract

BACKGROUND: Dual-chamber (DDDR) pacing preserves AV synchrony and may reduce heart failure (HF) and atrial fibrillation (AF) compared with ventricular (VVIR) pacing in sinus node dysfunction (SND). However, DDDR pacing often results in prolonged QRS durations (QRSd) as the result of right ventricular stimulation, and ventricular desynchronization may result. The effect of pacing-induced ventricular desynchronization in patients with normal baseline QRSd is unknown. METHODS AND
RESULTS: Baseline QRSd was obtained from 12-lead ECGs before pacemaker implantation in MOST, a 2010-patient, 6-year, randomized trial of DDDR versus VVIR pacing in SND. Cumulative percent ventricular paced (Cum%VP) was determined from stored pacemaker data. Baseline QRSd <120 ms was observed in 1339 patients (707 DDDR, 632 VVIR). Cum%VP was greater in DDDR versus VVIR (90% versus 58%, P=0.001). Cox models demonstrated that the time-dependent covariate Cum%VP was a strong predictor of HF hospitalization in DDDR (hazard ratio [HR], 2.99 [95% CI, 1.15 to 7.75] for Cum%VP >40%) and VVIR (HR 2.56 [95% CI, 1.48 to 4.43] for Cum%VP >80%). The risk of AF increased linearly with Cum%VP from 0% to 85% in both groups (DDDR, HR 1.36 [95% CI, 1.09, 1.69]; VVIR, HR 1.21 [95% CI 1.02, 1.43], for each 25% increase in Cum%VP). Model results were unaffected by adjustment for known baseline predictors of HF hospitalization and AF.
CONCLUSIONS: Ventricular desynchronization imposed by ventricular pacing even when AV synchrony is preserved increases the risk of HF hospitalization and AF in SND with normal baseline QRSd.

Entities:  

Mesh:

Year:  2003        PMID: 12782566     DOI: 10.1161/01.CIR.0000072769.17295.B1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  266 in total

1.  Physiologic pacing: where pacing mode selection reflects the indication.

Authors:  J S Healey; E Crystal; S J Connolly
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

2.  Rate control in atrial fibrillation: what approach is best?

Authors:  Brian Olshansky
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 3.  Right ventricular pacing, mechanical dyssynchrony, and heart failure.

Authors:  Alan J Bank; Ryan M Gage; Kevin V Burns
Journal:  J Cardiovasc Transl Res       Date:  2011-12-22       Impact factor: 4.132

4.  Acute and chronic response to CRT in narrow QRS patients.

Authors:  Tim Donahue; Imran Niazi; Angel Leon; Michael Stucky; Keith Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2011-12-30       Impact factor: 4.132

5.  Left ventricular pacing should be considered when biventricular pacing worsens heart failure: left ventricular pacing instead of biventricular pacing?

Authors:  Syed Y Ahsan; Matthew W Fittall; Aerakondal B Gopalamurugan; James W McCready; Laurence Nunn; Anthony W Chow
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

6.  Interventricular septal or standard apical pacing in pacing dependent patients: still a dilemma?

Authors:  Roxana Cristina Rimbas Sisu; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2010-07

7.  [Device therapy of chronic heart failure: Update 2015].

Authors:  C W Israel; L Ekosso-Ejangue; M-K Sheta
Journal:  Herz       Date:  2015-12       Impact factor: 1.443

Review 8.  Atrial fibrillation: profit from cardiac pacing?

Authors:  A Yang; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2005-03

Review 9.  Controversies in pacing: indications and programming.

Authors:  Anne M Gillis; Rik Willems
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 10.  Cardiac resynchronization therapy.

Authors:  Brian T Schuler; Angel R León
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.